Hellmich, B., & Löffler, C. (2026). Combination of rituximab and cyclophosphamide for induction of remission in ANCA-associated vasculitis: the stronger, the better?: Editorial. Clinical and experimental rheumatology, 44(4), . https://doi.org/10.55563/clinexprheumatol/bf8ssg
Chicago Style (17th ed.) CitationHellmich, Bernhard, and Christian Löffler. "Combination of Rituximab and Cyclophosphamide for Induction of Remission in ANCA-associated Vasculitis: The Stronger, the Better?: Editorial." Clinical and Experimental Rheumatology 44, no. 4 (2026). https://doi.org/10.55563/clinexprheumatol/bf8ssg.
MLA (9th ed.) CitationHellmich, Bernhard, and Christian Löffler. "Combination of Rituximab and Cyclophosphamide for Induction of Remission in ANCA-associated Vasculitis: The Stronger, the Better?: Editorial." Clinical and Experimental Rheumatology, vol. 44, no. 4, 2026, https://doi.org/10.55563/clinexprheumatol/bf8ssg.